First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States
| Autor: | McKay, Rana R., Morgans, Alicia K., Shore, Neal D., Dunshee, Curtis, Devgan, Geeta, Agarwal, Neeraj |
|---|---|
| Zdroj: | In Cancer Treatment Reviews May 2024 126 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect